Mycobacterium abscessus bacteremia after receipt of intravenous infusate of cytokine-induced killer cell therapy for body beautification and health boosting

Clinical Infectious Diseases

Volumn 57, Issue 7, 2013, Pages 981-991

  Liu, Raymond ^a   To, Kelvin K W ^a,b   Teng, Jade L L ^a   Choi, Garnet K Y ^a   Mok, Ka Yi ^a   Law, Kin Ip ^c   Tso, Eugene Y K ^c   Fung, Kitty S C ^c   Wu, Tak Chiu ^d   Wu, Alan K L ^e   Fung, Shing Hoi ^e   Wong, Sally C Y ^a   Trendell Smith, Nigel J ^f   Yuen, Kwok Yung ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b THE UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNITED CHRISTIAN HOSPITAL   (Hong Kong)

^d QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^e PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

^f QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Bacteremia; Beauty; Cytokine induced killer cell therapy; Mycobacterium abscessus; Sepsis

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFOXITIN; CILASTATIN PLUS IMIPENEM; CLARITHROMYCIN; ERTAPENEM; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 17; LEVOFLOXACIN; LINEZOLID; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; VANCOMYCIN;

ADRENAL HEMORRHAGE; ADRENAL NECROSIS; ADULT; ANTIBIOTIC THERAPY; ARTICLE; AUTOPSY; BACTEREMIA; BACTERIUM ISOLATION; BLOOD CULTURE; BLOOD SMEAR; CASE REPORT; CELL THERAPY; CORRELATION ANALYSIS; CYTOKINE INDUCED KILLER CELL; CYTOKINE PRODUCTION; DISEASE SEVERITY; ESTHETICS; FEMALE; FINGER AMPUTATION; GANGRENE; HEALTH STATUS; HUMAN; IMMUNOTHERAPY; LEG AMPUTATION; LUNG HEMORRHAGE; LUNG INFARCTION; LUNG INFILTRATE; LYMPHADENITIS; MENINGITIS; MYCOBACTERIOSIS; MYCOBACTERIUM ABSCESSUS; PRIORITY JOURNAL; RETINITIS; SEPTIC SHOCK; SPLEEN INFARCTION; THORAX RADIOGRAPHY; URINARY TRACT INFECTION;

BACTEREMIA; BEAUTY; CYTOKINE-INDUCED KILLER CELL THERAPY; MYCOBACTERIUM ABSCESSUS; SEPSIS;

ANTI-BACTERIAL AGENTS; BACTEREMIA; COSMETIC TECHNIQUES; CYTOKINE-INDUCED KILLER CELLS; FATAL OUTCOME; FEMALE; GANGRENE; HOSPITALIZATION; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA;

EID: 84884404508     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit443     Document Type: Article

References (40)

1. Wong SS, Wong SC, Yuen KY. Infections associated with body modification. J Formos Med Assoc 2012; 111:667-81.
2. Tang BSF, Chan JFW, Chen M, et al. Disseminated penicilliosis, recurrent bacteremic nontyphoidal salmonellosis, and burkholderiosis associated with acquired immunodeficiency due to autoantibody against gamma interferon. Clin Vaccine Immunol 2010; 17:1132-8.
3. Brown-Elliott BA, Nash KA, Wallace RJ Jr. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clin Microbiol Rev 2012; 25: 545-82.
4. Stout JE, Gadkowski LB, Rath S, Alspaugh JA, Miller MB, Cox GM. Pedicure-associated rapidly growing mycobacterial infection: an endemic disease. Clin Infect Dis 2011; 53:787-92.
5. Furuya EY, Paez A, Srinivasan A, et al. Outbreak of Mycobacterium abscessus wound infections among "lipotourists" from the United States who underwent abdominoplasty in the Dominican Republic. Clin Infect Dis 2008; 46:1181-8.
6. Galmes-Truyols A, Gimenez-Duran J, Bosch-Isabel C, et al. An outbreak of cutaneous infection due to Mycobacterium abscessus associated to mesotherapy. Enferm Infecc Microbiol Clin 2011; 29:510-4.
7. Choi WS, Kim MJ, Park DW, et al. Clarithromycin and amikacin vs. clarithromycin and moxifloxacin for the treatment of post-acupuncture cutaneous infections due to Mycobacterium abscessus: a prospective observational study. Clin Microbiol Infect 2011; 17:1084-90.
8. Yuan J, Liu YF, Yang ZC, et al. Mycobacterium abscessus post-injection abscesses from extrinsic contamination of multiple-dose bottles of normal saline in a rural clinic. Int J Infect Dis 2009; 13:537-42.
9. Yang ZB, Zhang BX, Lu QS, Chen LH, Liu XQ, Li HP. Large-scale outbreak of infection with Mycobacterium chelonae subsp abscessus after penicillin injection. J Clin Microbiol 2002; 40:2626-8.
10. Ashford DA, Kellerman S, Yakrus M, et al. Pseudo-outbreak of septicemia due to rapidly growing mycobacteria associated with extrinsic contamination of culture supplement. J Clin Microbiol 1997; 35:2040-2.
11. Dytoc MT, Honish L, Shandro C, et al. Clinical, microbiological, and epidemiological findings of an outbreak of Mycobacterium abscessus hand-and-foot disease. Diagn Microbiol Infect Dis 2005; 53:39-45.
12. Centre for Health Protection. Update on investigation of septic shock cases. Available at: http://www.chp.gov.hk/en/content/116/26649.html. Accessed 6 October 2012.
13. Hontscha C, Borck Y, Zhou H, Messmer D, Schmidt-Wolf IG. Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC). J Cancer Res Clin Oncol 2011; 137:305-10.
14. Bernard GR, Artigas A, Brigham KL, et al. Report of the American-European Consensus conference on acute respiratory distress syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Consensus Committee. J Crit Care 1994; 9:72-81.
15. Taylor FB Jr, Toh CH, Hoots WK, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86:1327-30.
16. To KK, Hung IF, Li IW, et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 2010; 50:850-9.
17. Lau SK, Curreem SO, Ngan AH, Yeung CK, Yuen KY, Woo PC. First report of disseminated Mycobacterium skin infections in two liver transplant recipients and rapid diagnosis by hsp65 gene sequencing. J Clin Microbiol 2011; 49:3733-8.
18. Chang CY, Tsay RW, Lin LC, Liu CE. Venous catheter-associated bacteremia caused by rapidly growing mycobacteria at a medical center in central Taiwan. J Microbiol Immunol Infect 2009; 42:343-50.
19. Jeon BY, Kwak J, Lee SS, et al. Comparative analysis of immune responses to Mycobacterium abscessus infection and its antigens in two murine models. J Microbiol 2009; 47:633-40.
20. Kassis I, Oren I, Davidson S, et al. Contamination of peripheral hematopoeitic stem cell products with a Mycobacterium mucogenicumrelated pathogen. Infect Control Hosp Epidemiol 2007; 28:755-7.
21. Lisboa T, Waterer G, Rello J. We should be measuring genomic bacterial load and virulence factors. Crit Care Med 2010; 38:S656-62.
22. Linares C, Bernabeu A, Luquin M, Valero-Guillen PL. Cord factors from atypical mycobacteria (Mycobacterium alvei, Mycobacterium brumae) stimulate the secretion of some pro-inflammatory cytokines of relevance in tuberculosis. Microbiology 2012; 158:2878-85.
23. Roux AL, Ray A, Pawlik A, et al. Overexpression of proinflammatory TLR-2-signalling lipoproteins in hypervirulent mycobacterial variants. Cell Microbiol 2011; 13:692-704.
24. Quesniaux VJ, Nicolle DM, Torres D, et al. Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans. J Immunol 2004; 172:4425-34.
25. Julian E, Roldan M, Sanchez-Chardi A, Astola O, Agusti G, Luquin M. Microscopic cords, a virulence-related characteristic of Mycobacterium tuberculosis, are also present in nonpathogenic mycobacteria. J Bacteriol 2010; 192:1751-60.
26. Chedid L, Parant M, Parant F, Gustafson RH, Berger FM. Biological study of a nontoxic, water-soluble immunoadjuvant from mycobacterial cell walls. Proc Natl Acad Sci U S A 1972; 69:855-8.
27. Huang CT, Chen CY, Chen HY, et al. Genitourinary infections caused by nontuberculous mycobacteria at a university hospital in Taiwan, 1996-2008. Clin Microbiol Infect 2010; 16:1585-90.
28. Guarner J, Paddock CD, Bartlett J, Zaki SR. Adrenal gland hemorrhage in patients with fatal bacterial infections. Mod Pathol 2008; 21:1113-20.
29. Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 2013; 13:260-8.
30. Mera S, Tatulescu D, Cismaru C, et al. Multiplex cytokine profiling in patients with sepsis. APMIS 2011; 119:155-63.
31. Punyadeera C, Schneider EM, Schaffer D, et al. A biomarker panel to discriminate between systemic inflammatory response syndrome and sepsis and sepsis severity. J Emerg Trauma Shock 2010; 3:26-35.
32. de Pablo R, Monserrat J, Reyes E, et al. Mortality in patients with septic shock correlates with anti-inflammatory but not proinflammatory immunomodulatory molecules. J Intensive Care Med 2011; 26: 125-32.
33. Rose WE, Eickhoff JC, Shukla SK, et al. Elevated serum interleukin-10 at time of hospital admission is predictive of mortality in patients with Staphylococcus aureus bacteremia. J Infect Dis 2012; 206:1604-11.
34. Wright KM, Friedland JS. Differential regulation of chemokine secretion in tuberculous and staphylococcal osteomyelitis. J Bone Miner Res 2002; 17:1680-90.
35. Chan ED, Bai X, Kartalija M, Orme IM, Ordway DJ. Host immune response to rapidly growing mycobacteria, an emerging cause of chronic lung disease. Am J Respir Cell Mol Biol 2010; 43:387-93.
36. Rottman M, Catherinot E, Hochedez P, et al. Importance of T cells, gamma interferon, and tumor necrosis factor in immune control of the rapid grower Mycobacterium abscessus in C57BL/6 mice. Infect Immun 2007; 75:5898-907.
37. van de Vosse E, van Dissel JT, Ottenhoff TH. Genetic deficiencies of innate immune signalling in human infectious disease. Lancet Infect Dis 2009; 9:688-98.
38. Jonsson B, Ridell M, Wold AE. Non-tuberculous mycobacteria and their surface lipids efficiently induced IL-17 production in human T cells. Microbes Infect 2012; 14:1186-95.
39. Tantawichien T, Young LS, Bermudez LE. Interleukin-7 induces anti-Mycobacterium avium activity in human monocyte-derived macrophages. J Infect Dis 1996; 174:574-82.
40. El Helou G, Viola GM, Hachem R, Han XY, Raad II. Rapidly growing mycobacterial bloodstream infections. Lancet Infect Dis 2013; 13: 166-74.